Articles On Nanollose (ASX:NC6)

ASX healthcare sector gains 1.99% in November while benchmark ASX 200 down 2.66% Mach7 rises 50% in November with health imaging stock outlining a growth strategy at its AGM  Island Pharmaceuticals rises after FDA confirms Galidesivir will...

ASX shrugs off hot CPI read, closes up 0.81% Gold, lithium, rare earths lead resources gains Broad upward momentum across eight sectors   Gold and lithium build momentum Lion Selection Group (ASX:LSX) MD Hedley Widdup predicted Australia...

ASX closes down 46 points or 0.52% Energy and rate-sensitive sectors lead losses Broad retreat with nine of 11 sectors lower   Tightening labour market smashes market The ASX 200 was already on struggle street through the morning, but wen...

ASX healthcare sector fell 4.83% in October and is down more than 19% YTD CSL shares fall more than 15% on October 28 after management trims FY26 guidance Nyrada surges 165% in October on board changes and progress in phase 2a trial    Wi...

Aussie and Asian markets fall after Trump threatens more tariffs on China Gold and silver reach new record highs with strong demand for safe haven assets Materials sector slips into red in afternoon trade as tech leads laggards   The Auss...

The S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on sector CSL had its biggest ever one day fall on August 19, down 17% following softer FY25 results and restructure plans Despite the broader...

The S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining momentum  Lumos soared 170% in July after six-year exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of Febri...

The ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6.64% Morgans healthcare analyst Iain Wilkie said June likely saw some tax loss selling before EOFY  Amplia up 300% in June after complete re...

The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump’s trade and health policies continue to impact sector Lumos up...

Highlights: XPON Technologies completes acquisition of Alpha Digital, supporting AI service expansion Anax Metals secures cornerstone backing for Whim Creek joint venture advancement ASX 200 dips in early trade amid declines...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10:15, once trading kicks off in earnes...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

ASX has gained to cinch seventh straight session in the green 10 of 11 sectors on the up Bank index lifts 1.6pc as CBA hits record new share price high The ASX is on trajectory to return to pre-trade war highs after lifting for a seventh...

ASX tanks 4pc, worst drop since may 2020 Gold, copper, Bitcoin hammered in global rout Abacus Storage King bursts up after receiving buyout proposal    The ASX has taken a big hit on Monday, dropping by 4% as it marked the worst one-day l...

Australia’s S&P/ASX 200 records its first back-to-back monthly fall since October 2023, down 3.39% in March Ten out 11 S&P/ASX 200 sectors posted losses with utilities the only sector in the black, up 1.52% Metal Powder Works rises...

ASX takes another hit, Trump’s tariffs to blame Albanese ignored by Trump ahead of tariff bombshell Retailers, miners, banks slump   Things got a bit ugly on the ASX on Wednesday with the benchmark ASX 200 index taking another big hit, th...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

ASX drops to 4-week low, miners lead losses Rio Tinto slumps after $2.5bn lithium investment, iron ore prices fall DigiCo REIT slips on IPO debut   The ASX has closed lower by 0.4% on Friday to near its lowest level in a month. For the we...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

ASX hits record high, driven by consumer stocks Zip co-founder steps down, Collins Foods drops Invion doubles after commencing phase I/II trial    The ASX hit a new record on Tuesday, marking its third all-time high in just a week.  At th...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

  ASX slips  amid earnings updates and company meetings AGL drops over 6pc after downgrade, while Origin Energy rises Talga surges after Sweden approves graphite mine   The ASX slipped by 0.22% after being dragged by a flurry of company...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

  ASX rises modestly with mining stocks leading gains Fortescue surges nearly 5pc as iron ore prices climb Star Entertainment plunges over 40pc after trading halt lifted   The ASX rose modestly by 0.1% on Friday, buoyed by a surge in min...

ASX down as RBA holds rates steady again Element 25 lands US$166m grant talks Supermarket stocks drop again amid discount claims backlash   The ASX was down 0.3% at one point but rallied to a flattish close after the Reserve Bank kept in...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

The ASX lagged on Thursday after Nvidia’s disappointing Q3 guidance Mineral Resources fell 8pc off a major profit drop Qantas saw a 28pc drop in profit but saw modest share price gains   The ASX was sluggish on Thursday, down 0.33%, follo...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

ASX rises on Thursday Nine sectors end higher, led by property stocks Small caps led by BEZ   The local benchmark index hit a record high this morning before trimming gains late. The S&P/ASX200 closed up Thursday, gaining 22.40 poi...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

Aussie shares rally Rate sensitive stocks gain, led by Tech FTL soars on Newfoundland deal   Aussie shares climbed strongly on Thursday closing above 7,820 as major global central banks began to cut interest rates and in the US, the S&amp...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

Tesltra slumps, iron ore miners gain BHP faces a deadline today to decide on its bid for Anglo America Webjet reveals plans to split its travel divisions, boosting its share price today   The ASX 200 closed flattish on Wednesday, as big l...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

  Local markets ride commodities lift to offset weak performance from Wall Street on Friday ASX 200 benchmark finished the day on +0.09pc, a lot higher than it really had any right to Resources led the way, overcoming a significant deadwei...

  ASX200 dragged down by bad drugs The IT Sector is up 1.1pc, Healthcare is down about 3.2pc Small cap winners led by American Rare Earths and Appen   The benchmark was shot through the heart by CSL this morning leaving everything else in...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

The ASX has ended the week lower, down 0.55pc on Friday Healthcare Sector remains defiant  Small caps led by medtech names and Lake Johnston lithium hunters   The fickle Aussie sharemarket has given back on Friday all that it has made thi...

Benchmark ASX index ends -0.6 lower Utilities only sector in the green Small caps led by LSA, AZS   The ASX200 has closed 42 points (-0.61%) lower on Thursday. May as well get you a pic. I’ll point out the important bits…   ASX200 ON THUR...

Benchmark ASX index closes short by -0.04% Materials sector tries but cannot offset everyone else  Small caps led by HAL, DTC   The ASX200 Index has closed slightly lower after jumping early (+0.3%) out the gates on Wednesday morning. The...

Benchmark ASX index closes ahead +0.19% Materials lead ASX sectors on Tuesday Small caps led by ERW, NMR   Local markets have struggled to hang onto early gains after a mixed run on Wall Street overnight. The benchmark ASX200 (XJO) index...

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...